Andreas Wicki, Director at Harmony Biosciences Holdings, Inc. (HRMY), sold 1,157,104 shares at $53.67 ($62.2M) on 2022-08-09, disclosed to the SEC on 2022-08-10.
Open-market sale of $62.2M HRMY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.94 | 486,360 | $26.2M | 42.2% |
| 2 | $53.94 | 486,360 | $26.2M | 42.2% |
| 3 | $53.67 | 20,745 | $1.1M | 1.8% |
| 4 | $53.67 | 20,745 | $1.1M | 1.8% |
| 5 | $52.61 | 71,447 | $3.8M | 6.0% |
| 6 | $52.61 | 71,447 |
| $3.8M |
| 6.0% |
| Total | $53.77 avg | 1,157,104 | $62.2M | 100% |
| Filing → |
| HRMY | SELL | 2022-11-16 | $6.1M | — | Filing → |
| HRMY | SELL | 2022-11-10 | $15.2M | — | Filing → |
| HRMY | SELL | 2022-11-04 | $68.2M | — | Filing → |